Batgi, H. Et Al. 2020. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience. Journal of Oncology Pharmacy Practice , vol.26, no.8 , 1857-1863.

Batgi, H., Merdin, A., Dal, M. S., Kızıl Çakar, M., Yıldız, J., Başçı, S., ... Uncu Ulu, B.(2020). The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience. Journal of Oncology Pharmacy Practice , vol.26, no.8, 1857-1863.

Batgi, Hikmettullah Et Al. "The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience," Journal of Oncology Pharmacy Practice , vol.26, no.8, 1857-1863, 2020

Batgi, Hikmettullah Et Al. "The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience." Journal of Oncology Pharmacy Practice , vol.26, no.8, pp.1857-1863, 2020

Batgi, H. Et Al. (2020) . "The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience." Journal of Oncology Pharmacy Practice , vol.26, no.8, pp.1857-1863.

@article{article, author={Hikmettullah Batgi Et Al. }, title={The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience}, journal={Journal of Oncology Pharmacy Practice}, year=2020, pages={1857-1863} }